Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an annual letter from CEO Chris Bunka and a thorough strategic update to all stakeholders. In the update, Bunka described Lexaria’s…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and beverage, biotherapeutics and personal wellness industries, among others,…
The study is available for public viewing and is entitled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” (https://ibn.fm/w6zLQ) Dr. Richard van Breeman, who headed the independent study, explained that smoking and vaping…
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that it will report financial results for its third quarter ended Dec. 31, 2021, on Thursday, Feb. 10,…
Six LiDAR companies have gone public since 2020, raising $3.6+ billion as investors look for exposure to autonomous vehicles market Cepton is merging with Growth Capital Acquisition Corp GCAC in the coming weeks in a…
Psychedelics pose potential as effective treatments for mental-health issues such as depression, anxiety, and substance abuse Well+Good says psychedelics “poised to change the course of mental health treatment” Cybin working to combine novel psychedelic molecules with controllable…
Multi-state cannabis operator Red White & Bloom Brands is developing opportunities strategically in sizable cannabis markets such as Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts The company recently announced it has secured full licensing…
Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is riding the popularity of its trademarked Platinum Vape to remarkable revenue growth, recording a 93% year-over-year increase in its recently released third-quarter financial report. “The…
FingerMotion (NASDAQ: FNGR) recently received approval for its application for up-listing to the Nasdaq Capital Market and subsequently commenced trading on Dec. 28, 2021, under the symbol FNGR. FingerMotion’s listing marks a significant milestone, particularly…
The global cannabinoid-based pharmaceuticals market is projected to be valued at $50 billion by 2029 InMed is leading the industry, laying down the foundation in manufacturing and clinical development of rare cannabinoids It is shedding…
SRAX will host their inaugural Metals & Mining Conference on January 27, 2022 The conference will be held on Sequire’s Virtual Events platform and will play host to over 70 companies along with a series…
Freakish Midwest tornados, devastating wildfires, extreme droughts, abnormal floods – all signal the onset of a changing global climate. There’s overwhelming concern about climate change, but it’s difficult to achieve consensus on actions to mitigate…
Tingo Inc. (OTC: IWBB) founder and CEO Dozy Mmobuosi was featured in a recent interview on The Daily Helping Podcast, a series focused on providing food for the brain, knowledge from the experts and tools…
AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that Frost & Sullivan Company, a leading and well-known U.S. market analysis and research firm, has ranked AnPac…
CNS Pharmaceuticals received approval from swissethics for its potentially pivotal study of Berubicin, a novel anthracycline for the treatment of Glioblastoma Multiforme (“GBM”) The approval is the first from a European Ethics Committee The company,…
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has announced preliminary unaudited results for 2021 with a processing record of $1.95 billion in transaction volume, compared to $202 million during the previous year.…
Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Derek Pedro, an industry-leading cannabis genetics and cultivation expert, as an advisor. Pedro is recognized as a…
Growth Capital Acquisition Corp. (NASDAQ: GCAC), a publicly traded special purpose acquisition company, and its upcoming merger with Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT(R) lidar solutions, will be…
Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently announced the rollout of its Miboko application by targeting insurers and employers In 2019, over $760 billion was…
Flora Growth just announced the production of its first batch of crude oil through its newly constructed facility in Colombia The company has also initiated the EU-GMP certification process that will allow it to target…
Save Foods (NASDAQ: SVFD), an agri-food tech company specializing in eco crop protection designed to reduce food waste and ensure food safety, has completed several successful trials with Galilee Export, the second largest exporter of…
Flora Growth Corp. (NASDAQ: FLGC) is entering 2022 with momentum from the past year’s aggressive growth campaign for its global cannabis-derivative brand distribution of pharmaceuticals, cosmetics and nutraceuticals. While the COVID-19 pandemic has had a…
Plant-based lifestyle brand builder PlantX Life Inc. offers more than 5,000 plant-based products through meal and indoor plant deliveries, and the company is working through research and development to introduce new product categories in the…
U.S.-based communications technology brand FingerMotion is building its profits as it focuses on services for China’s world-leading, mobile-connected population FingerMotion recently reported its financial statement for the Q3 quarter ending Nov. 30, noting gross profits…
Diabetes tech market expanded in 2021 due to new users, growing demand for CGM devices, coverage of CGM devices by CMS Diabetes is a growing problem in the US. According to CDC, roughly 1 in…
Lexaria Bioscience (NASDAQ: LEXX) CEO and chair Chris Bunka is the guest on a recent episode of the EDGE podcast. Hosted by entrepreneur and angel investor Brandon C. White, the EDGE is a podcast series…
Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatment The stage is also set for other R&D programs for the 2022 calendar year, including HOR-A22-1, DEM-A22-1, RHEUM-A22-1 and DIAB-A22-1…
SRAX’s performance goes from strength to strength; company announced revenue guidance expecting revenues of $11.5 million for the first quarter and full-year revenues of $46M – $48M. Company’s SaaS platform Sequire expected to continue to…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced that its CEO John Climaco will…
PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of its new YouTube series entitled “Medically Speaking,” designed to enhance plant-based education and equip consumers with the necessary knowledge to achieve their…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and services to the worldwide food and beverage, biotherapeutics and personal wellness industries, among others, today…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, aims to set itself apart from the rest of the automotive pack through the creation of a sophisticated and luxurious crossover EV-SUV, a vehicle that…
Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently received a notice of allowance from the U.S. Patent and Trademark Office (“USPTO”). The notice…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that it has launched B2B sales of the rare cannabinoid cannabicitran (“CBT”) into the health and wellness…
Company marked host of major milestones and accomplishments in 2021 Approvals, licenses, expansions and growth all essential pieces of Cybin success CYBN’s innovative operational and R&D pipeline platforms expected to support four first-in-human clinical studies…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has commented on a recent study that indicated that cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2. The comments came from…
Growth Capital Acquisition Corp. (NASDAQ: GCAC) and its wholly owned subsidiary, GCAC Merger Sub Inc., previously entered into a business combination agreement with Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance…
FingerMotion (NASDAQ: FNGR), a mobile data and services company, is reporting financial results for the third quarter, the period ended Nov. 30, 2021. Highlights of the report include quarterly revenue of $5.9 million, an increase…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced the quantity of shares repurchased in the fourth quarter of 2021,…
GreenBox (NASDAQ: GBOX), an emerging fintech company leveraging proprietary blockchain security and token technology to build customized payment solutions, has launched a significant new payment vertical. The new option offers bulk Automated Clearing House (“ACH”)…